about
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG)Implication of CpG-ODN and reactive oxygen species in the inhibition of intracellular growth of Salmonella typhimurium in hepatocytes.Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines.Correction: Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).A novel CD14(high) CD16(high) subset of peritoneal macrophages from cirrhotic patients is associated to an increased response to LPS.Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patientsICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytesInternational clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow upCD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating PathwayInfluence of liposome charge and composition on their interaction with human blood serum proteinsInterleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expressionInterleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients
P50
Q33592500-13EA93BD-A227-406C-A8EF-85CE5DC82E69Q35255198-120EECA9-EAAF-41DC-8A0F-BB37F4D72CBFQ36077532-8E1E8BD8-B6F4-4613-AB73-41DA05634A0DQ40514870-CBBFF436-713D-4025-B275-766F060AAF71Q40559694-2467212C-2028-4142-8F0F-88DE264F3862Q42379403-BC63B6C4-9D4F-445D-B446-B6C4340671F7Q42489897-EECFAD49-76A2-4449-9A30-DBACA5C2B35BQ56903825-032A42AC-1A25-4C60-8E4B-A5DBB41049B6Q58064677-5B33DA74-79D3-434A-8175-D2394BADD4B0Q64040674-C5E207D2-84A3-4F46-97CF-A3A6FD42C65CQ64241083-C0BE2DC7-DE7E-4B96-ACEF-68316C0CF9E8Q70699805-E590CBAD-853F-49D0-AB73-8FBC4DE651C9Q71742095-7D811999-9387-47D0-9E77-DD3A08334FF6Q78411681-3808F8EF-9BE9-43B2-B580-29FA8CC6EC8E
P50
description
researcher ORCID ID = 0000-0001-6727-8320
@en
wetenschapper
@nl
name
Trinidad Hernández-Caselles
@ast
Trinidad Hernández-Caselles
@en
Trinidad Hernández-Caselles
@es
Trinidad Hernández-Caselles
@nl
type
label
Trinidad Hernández-Caselles
@ast
Trinidad Hernández-Caselles
@en
Trinidad Hernández-Caselles
@es
Trinidad Hernández-Caselles
@nl
prefLabel
Trinidad Hernández-Caselles
@ast
Trinidad Hernández-Caselles
@en
Trinidad Hernández-Caselles
@es
Trinidad Hernández-Caselles
@nl
P106
P1153
6603601628
P31
P496
0000-0001-6727-8320